નસ-નસ માં બિઝનેસ
Ahmedabad, April 07th: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its […]
Ahmedabad, March 9: Alembic Pharmaceuticals Limited (“Alembic”) today announced the first prescription-based sale of Pivya (pivmecillinam) tablets, an oral prescription antibiotic, following its recent commercial […]
Ahmedabad, February 27th: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its […]
Ahmedabad 11th, December: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its […]
AHMEDABAD,17TH November: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated […]
AHMEDABAD, November 14th: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its […]
AHMEDABAD, 11THNovember: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated […]
AHMEDABAD, 08 October: Alembic Pharmaceuticals Ltd., through a strategic agreement with Amlan International, today announced the India launch of MinerTox-Z and MinerTox-A, feed additive solutions […]
